Prostate cancer (PCa) is a leading cause of mortality among males. Long non-coding RNAs
(lncRNAs) are subclass of noncoding RNAs that may act as biomarkers and therapeutic …

Abstract Background Long noncoding RNAs (lncRNAs) are RNA molecules with over 200
nucleotides that do not code for proteins, but are known to be widely expressed and have …

Whole genome transcriptomic analyses have identified a large number of long non-coding
RNAs (lncRNAs), many of which are involved in a variety of biological functions. However …

Prostate cancer is the most common cancer in men and the second leading cause of cancer-
related deaths. The most used biomarker to detect prostate cancer is Prostate Specific …

Whole genome transcriptomic analyses have identified numerous long non-coding RNA
(lncRNA) transcripts that are increasingly implicated in cancer biology. LncRNAs are found …

Long non-coding RNA (LncRNA) is defined as an RNA transcript that does not encode any
protein, with a length longer than 200 nt. Based on the recent advances in high-throughput …

Long noncoding RNAs (lncRNAs) are defined as RNA transcripts longer than 200
nucleotides that do not encode proteins. LncRNAs have been documented to exhibit …

Long non‐coding RNAs (lncRNAs) are RNA transcripts larger than 200 nucleotides that do
not code for proteins the aberrant expression of which has been documented in various …

Prostate cancer is the second most common cause of cancer mortality among men in the
United States. While many prostate cancers are indolent, an important subset of patients …

Background: The lack of sensitive and specific biomarkers for prostate cancer (PCa) has led
to over-diagnosis and overtreatment with uncertain benefit. Therefore, biomarkers for early …